Literature DB >> 35418688

Subretinal injection in mice to study retinal physiology and disease.

Peirong Huang1,2,3, Siddharth Narendran1,2,4, Felipe Pereira1,2,5, Shinichi Fukuda1,2,6, Yosuke Nagasaka1,2, Ivana Apicella1,2, Praveen Yerramothu1,2, Kenneth M Marion7, Xiaoyu Cai1,2, Srinivas R Sadda7,8, Bradley D Gelfand1,2,9, Jayakrishna Ambati10,11,12,13.   

Abstract

Subretinal injection (SRI) is a widely used technique in retinal research and can be used to deliver nucleic acids, small molecules, macromolecules, viruses, cells or biomaterials such as nanobeads. Here we describe how to undertake SRI of mice. This protocol was adapted from a technique initially described for larger animals. Although SRI is a common procedure in eye research laboratories, there is no published guidance on the best practices for determining what constitutes a 'successful' SRI. Optimal injections are required for reproducibility of the procedure and, when carried out suboptimally, can lead to erroneous conclusions. To address this issue, we propose a standardized protocol for SRI with 'procedure success' defined by follow-up examination of the retina and the retinal pigmented epithelium rather than solely via intraoperative endpoints. This protocol takes 7-14 d to complete, depending on the reagent delivered. We have found, by instituting a standardized training program, that trained ophthalmologists achieve reliable proficiency in this technique after ~350 practice injections. This technique can be used to gain insights into retinal physiology and disease pathogenesis and to test the efficacy of experimental compounds in the retina or retinal pigmented epithelium.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35418688     DOI: 10.1038/s41596-022-00689-4

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  50 in total

1.  Treatment of retinal folds using a modified macula relocation technique with perfluoro-hexyloctane tamponade.

Authors:  E N Herbert; C Groenewald; D Wong
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.

Authors:  Jianan Sun; Michiko Mandai; Hiroyuki Kamao; Tomoyo Hashiguchi; Masayuki Shikamura; Shin Kawamata; Sunao Sugita; Masayo Takahashi
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

3.  Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.

Authors:  Stephen Russell; Jean Bennett; Jennifer A Wellman; Daniel C Chung; Zi-Fan Yu; Amy Tillman; Janet Wittes; Julie Pappas; Okan Elci; Sarah McCague; Dominique Cross; Kathleen A Marshall; Jean Walshire; Taylor L Kehoe; Hannah Reichert; Maria Davis; Leslie Raffini; Lindsey A George; F Parker Hudson; Laura Dingfield; Xiaosong Zhu; Julia A Haller; Elliott H Sohn; Vinit B Mahajan; Wanda Pfeifer; Michelle Weckmann; Chris Johnson; Dina Gewaily; Arlene Drack; Edwin Stone; Katie Wachtel; Francesca Simonelli; Bart P Leroy; J Fraser Wright; Katherine A High; Albert M Maguire
Journal:  Lancet       Date:  2017-07-14       Impact factor: 79.321

4.  TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy.

Authors:  Nagaraj Kerur; Yoshio Hirano; Valeria Tarallo; Benjamin J Fowler; Ana Bastos-Carvalho; Tetsuhiro Yasuma; Reo Yasuma; Younghee Kim; David R Hinton; Carsten J Kirschning; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

5.  Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice.

Authors:  Sikai Ling; Shiqi Yang; Xinde Hu; Di Yin; Yao Dai; Xiaoqing Qian; Dawei Wang; Xiaoyong Pan; Jiaxu Hong; Xiaodong Sun; Hui Yang; Soren Riis Paludan; Yujia Cai
Journal:  Nat Biomed Eng       Date:  2021-01-04       Impact factor: 25.671

6.  Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.

Authors:  Benjamin J Fowler; Bradley D Gelfand; Younghee Kim; Nagaraj Kerur; Valeria Tarallo; Yoshio Hirano; Shoba Amarnath; Daniel H Fowler; Marta Radwan; Mark T Young; Keir Pittman; Paul Kubes; Hitesh K Agarwal; Keykavous Parang; David R Hinton; Ana Bastos-Carvalho; Shengjian Li; Tetsuhiro Yasuma; Takeshi Mizutani; Reo Yasuma; Charles Wright; Jayakrishna Ambati
Journal:  Science       Date:  2014-11-21       Impact factor: 47.728

7.  Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.

Authors:  Ji-jing Pang; Bo Chang; Ashok Kumar; Steven Nusinowitz; Syed M Noorwez; Jie Li; Asha Rani; Thomas C Foster; Vince A Chiodo; Thomas Doyle; Huashi Li; Ritu Malhotra; Jacqueline T Teusner; J Hugh McDowell; Seok-Hong Min; Qiuhong Li; Shalesh Kaushal; William W Hauswirth
Journal:  Mol Ther       Date:  2005-10-11       Impact factor: 11.454

8.  ERK1/2 activation is a therapeutic target in age-related macular degeneration.

Authors:  Sami Dridi; Yoshio Hirano; Valeria Tarallo; Younghee Kim; Benjamin J Fowler; Balamurali K Ambati; Sasha Bogdanovich; Vince A Chiodo; William W Hauswirth; Jennifer F Kugel; James A Goodrich; Steven L Ponicsan; David R Hinton; Mark E Kleinman; Judit Z Baffi; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

9.  DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.

Authors:  Valeria Tarallo; Yoshio Hirano; Bradley D Gelfand; Sami Dridi; Nagaraj Kerur; Younghee Kim; Won Gil Cho; Hiroki Kaneko; Benjamin J Fowler; Sasha Bogdanovich; Romulo J C Albuquerque; William W Hauswirth; Vince A Chiodo; Jennifer F Kugel; James A Goodrich; Steven L Ponicsan; Gautam Chaudhuri; Michael P Murphy; Joshua L Dunaief; Balamurali K Ambati; Yuichiro Ogura; Jae Wook Yoo; Dong-ki Lee; Patrick Provost; David R Hinton; Gabriel Núñez; Judit Z Baffi; Mark E Kleinman; Jayakrishna Ambati
Journal:  Cell       Date:  2012-04-26       Impact factor: 41.582

10.  DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration.

Authors:  Hiroki Kaneko; Sami Dridi; Valeria Tarallo; Bradley D Gelfand; Benjamin J Fowler; Won Gil Cho; Mark E Kleinman; Steven L Ponicsan; William W Hauswirth; Vince A Chiodo; Katalin Karikó; Jae Wook Yoo; Dong-ki Lee; Majda Hadziahmetovic; Ying Song; Smita Misra; Gautam Chaudhuri; Frank W Buaas; Robert E Braun; David R Hinton; Qing Zhang; Hans E Grossniklaus; Jan M Provis; Michele C Madigan; Ann H Milam; Nikki L Justice; Romulo J C Albuquerque; Alexander D Blandford; Sasha Bogdanovich; Yoshio Hirano; Jassir Witta; Elaine Fuchs; Dan R Littman; Balamurali K Ambati; Charles M Rudin; Mark M W Chong; Patrick Provost; Jennifer F Kugel; James A Goodrich; Joshua L Dunaief; Judit Z Baffi; Jayakrishna Ambati
Journal:  Nature       Date:  2011-02-06       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.